Alert on Racial Discrimination in COVID‑19 Vaccination
Abstract
Keywords
Full Text:
PDFReferences
World Health Organization. WHO Coronavirus
Disease (COVID‑19) Dashboard.Available from https://covid19.
who.int/. [Last accessed on 2021 Sep 15].
Hung IF, Poland GA. Single‑dose Oxford–AstraZeneca
COVID‑19 vaccine followed by a 12‑week booster. Lancet
;397:854‑5.
Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi‑Newton S,
Kong M‑F, et al. High‑dose cholecalciferol booster therapy
is associated with areduced risk of mortality in patients with
COVID‑19: A cross‑sectional multi‑centre observational study.
Nutrients 2020;12:3799. doi: 10.3390/nu12123799.
Airfinity. China administers its billionth vaccine dose, on track to
be fully vaccinated by the end of 2021. Available from: https://
www.airfinity.com/insights/analysis‑1. [Last accessed on 2021
Jun 23].
SchengenVisaInfo.com. Available from: https://www.
schengenvisainfo.com/news/travel-to-france-which-covid-19‑vacc
ines‑are‑accepted‑as‑proof‑of‑immunity/. [Last accessed on 2021
Jul 12].